Bollywood couldn't have been more conspicuous by its absence in movie theatres this year, with nearly the full April-June quarter going by without any big releases. The industry was hit hard by the Lok Sabha elections and IPL (Indian Premier League) between April and May, and just a handful of titles attracted audiences to the theatres.
Trade experts estimate Hindi film revenue in 2024 to be at least 30-40% lower than in 2023, and the overall Indian movie box office, across languages, likely flat or 10-15% lower this year. Last year, the movie industry earned ₹12,000 crore in earnings, according to consulting firm Ormax.
There is more bad news for Bollywood: at ₹72 crore, the Hindi-dubbed version of Telugu action film Pushpa 2: The Rule has made for the second highest opening day ever in the Hindi-speaking belt, beating many original Hindi language films. In terms of total collections, it has beaten all original Hindi language hits, and is now the highest grosser in the Bollywood market.
The only Bollywood titles to have made a mark this year are horror comedy Stree 2 (₹627.02 crore), Bhool Bhulaiyaa 3 (₹278.42 crore) and Singham Again (₹268.35 crore). The numbers have been sourced from Bollywood Hungama.
On the other hand, success stories in the Tamil and Malayalam industries are quite a few-Amaran (Tamil, ₹216 crore), Manjummel Boys (Malayalam, ₹153 crore), Vettaiyan (Tamil, ₹143 crore), Aavesham (Malayalam, ₹97 crore), Premalu (Malayalam, ₹75 crore), and Maharaja (Tamil, ₹72 crore).
"The box office is currently tracking similar to or slightly lower than last year's numbers," said Sanjeev Kumar Bijli, executive director, PVR Inox Ltd.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Inside the Seismic Shift in the Namkeen World
Health is wealth, so many brands are coming up with all kinds of products to reshape the way Indians snack
American employees have lost their labour market leverage
Their pandemic gains are over as the power balance tilts away
Donald Trump to take virtual centre stage in Davos
Chief executives will be given the chance to lob questions at the new US President Donald Trump
Little-known ETF gains from SpaceX addition
The fund has since seen the best stretch of flows in its seven-year lifespan
Adani Infra seeks CCI clearance
Adani Infra has sought approval from fair trade regulator Competition Commission of India (CCI) for acquiring a majority stake in PSP Projects Ltd.
Declaring pre-existing diseases and timelines: Know the rules
What is the time limit for pre-existing diseases when buying health insurance?
Uneven access to formal credit can set our economic goals back
India must chart a path for small-ticket formal credit if it is to realize its Viksit Bharat ambition
Maruti Suzuki to up prices of models
Maruti Suzuki India Ltd (MSIL) on Thursday said it will hike prices by up to ₹32,500 across various models to partially offset the rise in input costs.
HUL's Minimalist asset big push for beauty portfolio
India's largest consumer goods maker just acquired one of the few profitable personal care startups in the country, signaling more consolidation as entrenched giants beef up premium offerings.
HUL needs a magic wand for recovery after subdued Q3
Not fast-moving
